Latest News
Latest News
  • Home
  • Video Shows
    VantageFirstpost AmericaFirstpost AfricaFirst Sports
  • World
    US News
  • Explainers
  • News
    IndiaOpinionCricketTechEntertainmentSportsHealthPhotostories
TrendingDonald TrumpNarendra ModiElon MuskUnited StatesJoe Biden
Latest News

Sections

  • Home
  • Live TV
  • Videos
  • Shows
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Health
  • Tech/Auto
  • Entertainment
  • Web Stories
  • Business
  • Impact Shorts

Shows

  • Vantage
  • Firstpost America
  • Firstpost Africa
  • First Sports
  • Fast and Factual
  • Between The Lines
  • Flashback
  • Live TV

Events

  • Raisina Dialogue
  • Independence Day
  • Champions Trophy
  • Delhi Elections 2025
  • Budget 2025
  • US Elections 2024
  • Firstpost Defence Summit

Pfizer Covid19 Vaccine

Recent Highlights

US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine

US health experts recommend Pfizer, Moderna COVID-19 shots over J&J vaccine

.
Discussions on with Indian govt for expedited approval of COVID-19 vaccine, says Pfizer

Discussions on with Indian govt for expedited approval of COVID-19 vaccine, says Pfizer

.
COVID-19: Pfizer-BioNTech vaccine 100% effective in 12 to 15-year-olds, say companies

COVID-19: Pfizer-BioNTech vaccine 100% effective in 12 to 15-year-olds, say companies

.
Donald Trump signs ‘America First’ COVID-19 vaccine executive order, says FDA approval expected soon

Donald Trump signs ‘America First’ COVID-19 vaccine executive order, says FDA approval expected soon

.

All Stories for Pfizer Covid19 Vaccine

All (6)
  • Tokyo Olympics 2020: Games organisers hail vaccine news as 'relief' yet bio-security plans unchanged

    Tokyo Olympics 2020: Games organisers hail vaccine news as 'relief' yet bio-security plans unchanged

    • .

    Olympic officials have regularly said that a coronavirus vaccine is not a precondition for staging the Games, now scheduled to open a year late in July 2021.

  • Pfizer announces $1.95 billion deal to produce 100 million doses of coronavirus vaccine by year-end

    Pfizer announces $1.95 billion deal to produce 100 million doses of coronavirus vaccine by year-end

    • .

    Pfizer said that large-scale safety and efficacy trials were to begin this month, with a regulatory review set for as early as October, although nothing was guaranteed.

  • Home
  • pfizer covid19 vaccine

About Firstpost

Most Searched Categories

  • Web Stories
  • World
  • India
  • Explainers
  • Opinion
  • Sports
  • Cricket
  • Tech/Auto
  • Entertainment
  • IPL 2025

NETWORK18 SITES

  • News18
  • Money Control
  • CNBC TV18
  • Forbes India
  • Advertise with us
  • Sitemap
youtube
youtube

is on YouTube

Subscribe Now

Copyright @ 2025. Firstpost - All Rights Reserved.

Contact Us Privacy Policy Cookie Policy Terms Of Use
HomeVideosShortsLive TV